2011年欧洲器官移植年会肾移植研究热点荟萃
被引量：1
2011年欧洲器官移植年会肾移植研究热点荟萃
摘要
2011年9月4—7日，第15届欧洲器官移植年会在英国苏格兰格拉斯哥召开，来自世界各地的器官移植领域的专家和学者参加这次盛会。本次大会围绕移植物长期存活、边缘供者的应用、新型免疫抑制剂、免疫耐受等多个方面进行了深入交流。本文就肾移植研究热点问题作一简介。
出处
《中华移植杂志（电子版）》
CAS
2012年第1期54-57,共4页
Chinese Journal of Transplantation(Electronic Edition)
关键词
欧洲器官移植年会
肾移植
贝拉西普
长期存活
边缘供者
免疫耐受
Annual Meeting of European Organ Transplant Society
Kidney transplantation
Belatacept
Long-term survival
Marginal donor
Immune tolerance
参考文献29
-
1Israni A,Skeans M,Snyder JJ. Risk factors for new onset diabetes post kidney transplant and association with allograft failure:data from the international port study[J].Transplant International,2011,(Suppl 2):17.
-
2Tatar E,Demirci MS,Gungor O. Pre-transplant HbAlc level is an early predictive marker for new-onset diabetes mellitus in renal transplant recipients[J].Transplant International,2011,(Suppl 2):235.
-
3Mark PB,Traynor JP,McLaughlin K. Recipient M235T polymorphism of the angiotensinogen gene predicts long-term graft survival in kidney transplantation[J].Transplant International,2011,(Suppl 2):17.
-
4Domanski L,Dutkiewicz G,Kloda K. Is there an association of glutathione peroxidase(GPX1)gene polymorphism with posttransplant glucose metabolism disorder[J].Transplant International,2011,(Suppl 2):18.
-
5Süsal C,D(o)hler B,Sadeghi M. Posttransplant sCD30 as a biomarker to predict kidney graft outcome[J].Transplant International,2011,(Suppl 2):61.
-
6Morales JM,Marcen R,Castillo DD. The critical role of renal function,proteinuria and cardiovascular disease on the results after renal tansplantation.A prospective muhicenter study at five years according recipient age[J].Transplant International,2011,(Suppl 2):61.
-
7Sellarés J,de Freitas DG,Mengel M. Understanding the causes of kidney transplant failure:the dominant role of antibodymediated rejection and noandherence[J].American Journal of Transplantation,2011,(02):388-399.
-
8Montgomery RA,Locke JE,King KE. ABO incompatible renal transplantation:a paradigm ready for broad implementation[J].Transplantation,2009,(08):1246-1255.doi:10.1097/TP.0b013e31819f2024.
-
9Lefaucheur C,Antoine C,Suberbielle C. Mastering the risk of HLA antibodies in kidney transplantation:an algorithm based on pretransplant single-antigen flow bead techniques[J].American Journal of Transplantation,2011,(08):1592-1598.doi:10.1111/j.1600-6143.2011.03560.x.
-
10Hoogland ERP,Snoeijs MGJ,van Heum LWE. DCD kidney transplantation:long-term results of uncontrolled versus controlled donors[J].Transplant International,2011,(Suppl 2):44.
同被引文献11
-
1Chen L.Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity[].Nature Reviews Immunology.2004
-
2Rothstein DM,Sayegh MH.T-cell costimulatory pathways in allograft rejection and tolerance[].Immunological Reviews.2003
-
3Stamper C C,Zhang Y,Tobin J F,et al.Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses[].Nature.2001
-
4Schwartz J C,Zhang X,Fedorov A A,et al.Structural basis for co-stimulation by the human CTLA-4/B7-2 complex[].Nature.2001
-
5Joanna Ashton-Chess,Sophie Brouard and Jean-Paul Soulillou.Is clinical tolerance realistic in the next decade?[].Transplant International.2006
-
6Collins AV,Brodie DW,Gilbert RJ et al.The interaction properties of costimulatory molecules revisited[].Immunity.2002
-
7Magott Procelewska M,,Kosmaczewska A,Frydecka I,et al.Variable expression of CD28costimulatory molecule and CTLA4inhibitory molecule on peripheral blood CD4+cells in kidney allograft recipients with and without acute graft rejection[].Pol Merkur Lekarski.2006
-
8Ballet C,Roussey-Kesler G,Aubin JT,et al.Humoral and cellular re-sponses to influenza vaccination in human recipients naturally tolerant to a kidney allograft[].American Journal of Transplantation.2006
-
9Linsley PS,Nadler SG.The clinical utility of inhibiting CD28-mediated costimulation[].Immunological Reviews.2009
-
10Larsen CP,GrinyóJ,Medina-Pestana J,et al.Belatacept-based reg-imens versus a cyclosporine A-based regimen in kidney transplant re-cipients:2-year results from the BENEFIT and BENEFIT-EXT stud-ies[].Transplantation.2010
-
1林涛,王莉.2011年欧洲器官移植年会荟萃[J].实用医院临床杂志,2011,8(6):44-46.
-
2孟醒初,朱志军.肝移植中老年供者的选择及相关问题[J].中华外科杂志,2008,46(1):67-69.
-
3新普乐可复@在肾移植中的应用——第15届欧洲器官移植年会相关报告概述[J].中华器官移植杂志,2011,32(10).
-
4张小东.他克莫司缓释胶囊在肾移植中的临床研究——2015年第十七届欧洲器官移植年会研究结果的解读[J].中华器官移植杂志,2015,36(10):616-619. 被引量：1
-
5石蕊.边缘供肝在移植中的应用[J].中华器官移植杂志,2009,30(7):446-448. 被引量：1
-
6边缘供者对肝脏保存损伤的影响[J].传染病网络动态,2002(11):11-11.
-
7赵闻雨.聚乙二醇在器官保存中的应用及作用机制[J].中华器官移植杂志,2009,30(4):252-254. 被引量：4
-
8韩敬泉,崔键.无心跳供者供肺的低温保护技术[J].中华器官移植杂志,2009,30(3):191-192.
-
9颜晓勇,黄妍,陆清竹,杨亦彬,梁国标.亲属活体肾移植一例报道[J].遵义医学院学报,2008,31(6):639-640.
-
10正确理解“CNI肾毒性” 合理选择免疫抑制方案—-第15届欧洲器官移植年会侧记[J].中华器官移植杂志,2011,32(11).
